Vaughan Nelson Investment Management’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-600,400
Closed -$7.34M 216
2022
Q4
$7.34M Sell
600,400
-22,431
-4% -$280K 0.1% 148
2022
Q3
$7.73M Sell
622,831
-1,741,070
-74% -$30.4M 0.11% 130
2022
Q2
$46.4M Sell
2,363,901
-107,431
-4% -$2.54M 0.63% 47
2022
Q1
$64.5M Sell
2,471,332
-69,713
-3% -$1.86M 0.73% 38
2021
Q4
$72.1M Sell
2,541,045
-317,076
-11% -$9.86M 0.74% 35
2021
Q3
$91.1M Buy
2,858,121
+405,737
+17% +$13.6M 0.93% 29
2021
Q2
$85.1M Buy
+2,452,384
New +$80.9M 0.86% 34

Other funds holding ELAN

Vaughan Nelson Investment Management's ELAN Position: Q1 2023 in Review

Vaughan Nelson Investment Management sold out of Elanco Animal Health (ELAN) in Q1 2023, closing a stake of 600,400 shares — an estimated $7.34M sold.

Vaughan Nelson Investment Management first reported a position in ELAN in Q2 2021 and held it in 7 quarters. The position peaked at $91.1M in Q3 2021. 389 funds tracked by Wall St. Rank hold ELAN as of Q1 2023.

  • Vaughan Nelson Investment Management reported no remaining Elanco Animal Health position as of Q1 2023 after selling out during the quarter.
  • Vaughan Nelson Investment Management sold 600,400 Elanco Animal Health shares in Q1 2023, an estimated $7.34M.
  • Vaughan Nelson Investment Management first reported a position in Elanco Animal Health in Q2 2021 and held it in 7 quarters.
  • Vaughan Nelson Investment Management's Elanco Animal Health position peaked at $91.1M in Q3 2021.
  • 389 funds tracked by Wall St. Rank held Elanco Animal Health as of Q1 2023.

Based on Vaughan Nelson Investment Management's 13F filing for Q1 2023, filed 8 May 2023.